The current and future faces of stereotactic body radiation therapy for thoracic malignancies.
作者信息
Choi J Isabelle, Simone Charles B
机构信息
Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
出版信息
Transl Lung Cancer Res. 2019 Feb;8(1):1-4. doi: 10.21037/tlcr.2018.12.10.
Abstract
摘要
相似文献
1
The current and future faces of stereotactic body radiation therapy for thoracic malignancies.立体定向体部放射治疗在胸部恶性肿瘤治疗中的现状与未来展望
Transl Lung Cancer Res. 2019 Feb;8(1):1-4. doi: 10.21037/tlcr.2018.12.10.
2
PET-Based Thoracic Radiation Oncology.基于正电子发射断层扫描的胸部放射肿瘤学
PET Clin. 2016 Jul;11(3):319-32. doi: 10.1016/j.cpet.2016.03.001. Epub 2016 Apr 6.
3
Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies.立体定向体部放射治疗在上消化道恶性肿瘤管理中的应用
Biomedicines. 2018 Jan 3;6(1):7. doi: 10.3390/biomedicines6010007.
4
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.肝细胞癌的立体定向体部放射治疗：当前趋势与争议
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790217. doi: 10.1177/1533033818790217.
5
The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings.立体定向体放射治疗在局部晚期和转移性胃肠恶性肿瘤中的应用。
Clin Colorectal Cancer. 2010 Jul;9(3):136-43. doi: 10.3816/CCC.2010.n.018.
6
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].[常规分割放疗和立体定向体部放疗的肺部剂量限制]
Cancer Radiother. 2017 Oct;21(6-7):584-596. doi: 10.1016/j.canrad.2017.07.046. Epub 2017 Sep 5.
7
Stereotactic body radiation therapy: scope of the literature.立体定向体部放射治疗：文献范围。
Ann Intern Med. 2011 Jun 7;154(11):737-45. doi: 10.7326/0003-4819-154-11-201106070-00343. Epub 2011 May 2.
8
Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risks.胸段再放疗的立体定向体部放疗回顾：关注毒性风险。
Pract Radiat Oncol. 2018 Jul-Aug;8(4):251-265. doi: 10.1016/j.prro.2018.01.008.
9
Stereotactic body radiation therapy for lung cancer: achievements and perspectives.立体定向体部放疗治疗肺癌：成就与展望。
Jpn J Clin Oncol. 2010 Sep;40(9):846-54. doi: 10.1093/jjco/hyq134. Epub 2010 Jul 29.
10
Combining stereotactic body radiation therapy with immunotherapy: current data and future directions.立体定向体部放射治疗与免疫治疗相结合：当前数据与未来方向。
Transl Lung Cancer Res. 2019 Feb;8(1):107-115. doi: 10.21037/tlcr.2018.08.16.
引用本文的文献
1
Comparison of dosimetric effects of MLC positional errors on VMAT and IMRT plans for SBRT radiotherapy in non-small cell lung cancer.比较非小细胞肺癌 SBRT 放疗中 VMAT 和 IMRT 计划中 MLC 位置误差的剂量学效应。
PLoS One. 2022 Dec 1;17(12):e0278422. doi: 10.1371/journal.pone.0278422. eCollection 2022.
2
The protective effects of granulocyte-macrophage colony-stimulating factor against radiation-induced lung injury.粒细胞-巨噬细胞集落刺激因子对辐射诱导的肺损伤的保护作用。
Transl Lung Cancer Res. 2020 Dec;9(6):2440-2459. doi: 10.21037/tlcr-20-1272.
本文引用的文献
1
Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer.肺癌放射治疗中运动管理和图像引导应用的进展。
J Thorac Dis. 2018 Aug;10(Suppl 21):S2437-S2450. doi: 10.21037/jtd.2018.01.155.
2
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.无法手术的 I 期非小细胞肺癌立体定向体部放疗的长期结果。
JAMA Oncol. 2018 Sep 1;4(9):1287-1288. doi: 10.1001/jamaoncol.2018.1258.
3
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.局限性转移性非小细胞肺癌的巩固性放疗：一项 2 期随机临床试验。
JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501.
4
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.Durvalumab 用于 III 期非小细胞肺癌放化疗后的治疗。
N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8.
5
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.立体定向体部放射治疗早期非小细胞肺癌：ASTRO 循证指南的执行摘要。
Pract Radiat Oncol. 2017 Sep-Oct;7(5):295-301. doi: 10.1016/j.prro.2017.04.014. Epub 2017 Jun 5.
6
Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis.根据是否加用化疗和预防性颅脑照射，立体定向体部放疗治疗 T1-T2N0 小细胞肺癌的结果：一项多中心分析。
Clin Lung Cancer. 2017 Nov;18(6):675-681.e1. doi: 10.1016/j.cllc.2017.03.009. Epub 2017 Mar 16.
7
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.I期非小细胞肺癌患者立体定向消融放疗后的7年随访：一项2期临床试验的结果
Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.
8
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.分割方案和肿瘤位置对大（≥5厘米）非小细胞肺癌立体定向体部放射治疗后毒性的影响：一项多机构分析
Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):778-785. doi: 10.1016/j.ijrobp.2016.11.049. Epub 2016 Dec 2.
9
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.立体定向消融放疗治疗Ⅰ期小细胞肺癌的多机构经验
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2.
10
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.一线全身治疗后无进展的寡转移性非小细胞肺癌患者的局部巩固治疗与维持治疗或观察比较：一项多中心、随机、对照、2期研究
Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24.
Zotero 插件